| 注册
首页|期刊导航|中国临床药理学与治疗学|CYP2E1调控酒精性肝病发病机制的研究进展

CYP2E1调控酒精性肝病发病机制的研究进展

陈丹 林秀贤 陈尧

中国临床药理学与治疗学2017,Vol.22Issue(2):198-203,6.
中国临床药理学与治疗学2017,Vol.22Issue(2):198-203,6.

CYP2E1调控酒精性肝病发病机制的研究进展

Research on the progress of alcoholic liver disease pathogenesis related to CYP2E1

陈丹 1林秀贤 2陈尧1

作者信息

  • 1. 中南大学湘雅医院临床药理研究所,长沙410000,湖南
  • 2. 中南大学临床药理研究所,湖南省遗传药理学重点实验室,长沙410000,湖南
  • 折叠

摘要

Abstract

Alcoholic liver disease (ALD) is a kind of liver damage caused by long-term drink or heavy drink by a couple of weeks.Cytochrome P450 2El (CYP2E1),as a main enzyme metabolizing enzyme of alcohol,plays an important role in the toxic metabolism of alcohol and the occurrence and development of ALD.The expression of CYP2E1 in vivo,the activity of CYP2E1 and free oxygen radicals and toxic metabolites produced during the metabolism of alcohol by CYP2E1 can affect the process and development of ALD in different ways.The regulation mechanisms related to CYP2E1 is involved with multiples of pathogenic molecules,pathogenesis and signaling pathways.The interplay and reciprocal action between signaling pathways could have an influence on self-protection and the occurrence and development of ALD.This review mainly summarizes the research progresses of signaling pathways both in protective and injury mechanisms that regulate the progress of ALD through CYP2E1.Our effort could provide help for the prevention and treatment of ALD in future.

关键词

酒精性肝病(ALD)/CYP2E1/Wnt-β-catenin/JNK-MAPK/NF-κB/TGF-β-Smads

Key words

alcoholic liver disease/CYP2E1/Wnt-beta-catenin/JNK-MAPK/NF-κB/TGF-β-Smads

分类

医药卫生

引用本文复制引用

陈丹,林秀贤,陈尧..CYP2E1调控酒精性肝病发病机制的研究进展[J].中国临床药理学与治疗学,2017,22(2):198-203,6.

基金项目

国家自然科学基金项目(81302850) (81302850)

长沙市科技计划项目(kq1602014) (kq1602014)

中南大学中央高校基本科研业务费专项基金资助(2016zzts512) (2016zzts512)

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文